See more : Transportation and Logistics Systems, Inc. (TLSS) Income Statement Analysis – Financial Results
Complete financial analysis of Colgate-Palmolive Company (CL) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Colgate-Palmolive Company, a leading company in the Household & Personal Products industry within the Consumer Defensive sector.
You may be interested
- SDIC Power Holdings Co., Ltd. (600886.SS) Income Statement Analysis – Financial Results
- Kudelski SA (0QNQ.L) Income Statement Analysis – Financial Results
- CMC Metals Ltd. (CMB.V) Income Statement Analysis – Financial Results
- Gendai Agency Inc. (2411.T) Income Statement Analysis – Financial Results
- BASF India Limited (BASF.BO) Income Statement Analysis – Financial Results
Colgate-Palmolive Company (CL)
Industry: Household & Personal Products
Sector: Consumer Defensive
Website: https://www.colgatepalmolive.com
About Colgate-Palmolive Company
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 | 1985 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 19.46B | 17.97B | 17.42B | 16.47B | 15.69B | 15.54B | 15.45B | 15.20B | 16.03B | 17.28B | 17.42B | 17.09B | 16.73B | 15.56B | 15.33B | 15.33B | 13.79B | 12.24B | 11.40B | 10.58B | 9.90B | 9.29B | 9.43B | 9.36B | 9.12B | 8.97B | 9.06B | 8.75B | 8.36B | 7.59B | 7.14B | 7.01B | 6.06B | 5.69B | 5.04B | 4.73B | 5.65B | 4.98B | 4.52B |
| Cost of Revenue | 8.21B | 7.72B | 7.05B | 6.45B | 6.37B | 6.31B | 6.17B | 6.07B | 6.64B | 7.17B | 7.22B | 7.15B | 7.14B | 6.36B | 6.32B | 6.70B | 6.04B | 5.54B | 5.19B | 4.75B | 4.46B | 4.22B | 4.24B | 4.27B | 3.88B | 3.96B | 4.14B | 4.13B | 4.05B | 3.68B | 3.52B | 3.52B | 3.15B | 2.99B | 2.75B | 2.64B | 3.07B | 2.80B | 2.61B |
| Gross Profit | 11.25B | 10.25B | 10.38B | 10.02B | 9.33B | 9.23B | 9.28B | 9.12B | 9.40B | 10.11B | 10.20B | 9.93B | 9.59B | 9.20B | 9.01B | 8.63B | 7.75B | 6.70B | 6.21B | 5.84B | 5.45B | 5.07B | 5.19B | 5.09B | 5.23B | 5.01B | 4.92B | 4.61B | 4.31B | 3.91B | 3.62B | 3.49B | 2.91B | 2.70B | 2.29B | 2.09B | 2.58B | 2.18B | 1.92B |
| Gross Profit Ratio | 57.82% | 57.04% | 59.55% | 60.82% | 59.42% | 59.39% | 60.05% | 60.04% | 58.62% | 58.51% | 58.56% | 58.13% | 57.31% | 59.14% | 58.77% | 56.27% | 56.18% | 54.76% | 54.44% | 55.15% | 55.00% | 54.55% | 55.06% | 54.42% | 57.41% | 55.86% | 54.27% | 52.74% | 51.51% | 51.53% | 50.71% | 49.82% | 48.02% | 47.38% | 45.50% | 44.17% | 45.68% | 43.77% | 42.34% |
| Research & Development | 343.00M | 320.00M | 307.00M | 290.00M | 281.00M | 277.00M | 285.00M | 289.00M | 274.00M | 277.00M | 267.00M | 259.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 229.20M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 4.87B | 4.57B | 4.41B | 4.07B | 3.88B | 5.39B | 5.50B | 5.25B | 5.46B | 5.98B | 6.22B | 5.93B | 5.76B | 5.41B | 5.28B | 5.42B | 4.97B | 4.36B | 3.92B | 2.33B | 3.30B | 3.03B | 3.26B | 3.30B | 3.25B | 3.20B | 3.24B | 3.05B | 2.88B | 2.63B | 2.46B | 2.50B | 2.48B | 2.02B | 1.76B | 1.65B | 2.09B | 1.76B | 1.57B |
| Selling & Marketing | 2.37B | 2.00B | 2.00B | 1.95B | 1.69B | 1.59B | 1.57B | 1.43B | 1.49B | 1.78B | 1.89B | 1.79B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.06B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 7.24B | 6.57B | 6.41B | 6.02B | 5.58B | 5.39B | 5.50B | 5.25B | 5.46B | 5.98B | 6.22B | 5.93B | 5.76B | 5.41B | 5.28B | 5.42B | 4.97B | 4.36B | 3.92B | 3.40B | 3.30B | 3.03B | 3.26B | 3.30B | 3.25B | 3.20B | 3.24B | 3.05B | 2.88B | 2.63B | 2.46B | 2.50B | 2.48B | 2.02B | 1.76B | 1.65B | 2.09B | 1.76B | 1.57B |
| Other Expenses | 0.00 | 69.00M | 65.00M | 113.00M | 196.00M | -87.00M | 36.00M | 22.00M | 39.00M | 14.00M | 27.00M | 30.00M | -9.00M | 301.00M | 111.00M | 183.40M | 65.70M | 32.80M | 69.20M | 22.20M | -74.30M | 23.00M | 68.00M | 72.10M | 340.20M | 330.30M | 319.90M | 316.30M | 300.30M | 235.10M | 209.60M | 192.50M | 146.20M | 126.20M | 97.00M | 82.00M | 101.30M | 89.30M | 72.20M |
| Operating Expenses | 7.34B | 6.63B | 6.47B | 6.13B | 5.77B | 5.54B | 5.69B | 5.27B | 5.53B | 6.55B | 6.65B | 6.04B | 5.75B | 5.41B | 5.39B | 5.61B | 5.04B | 4.39B | 3.99B | 3.65B | 3.22B | 3.06B | 3.33B | 3.37B | 3.59B | 3.53B | 3.56B | 3.37B | 3.18B | 2.86B | 2.67B | 2.69B | 2.63B | 2.14B | 1.86B | 1.73B | 2.20B | 1.85B | 1.64B |
| Cost & Expenses | 15.47B | 14.35B | 13.52B | 12.59B | 12.14B | 11.85B | 11.87B | 11.34B | 12.16B | 13.72B | 13.86B | 13.20B | 12.89B | 11.77B | 11.71B | 12.31B | 11.08B | 9.92B | 9.18B | 8.39B | 7.68B | 7.28B | 7.57B | 7.64B | 7.48B | 7.49B | 7.70B | 7.50B | 7.23B | 6.54B | 6.19B | 6.21B | 5.78B | 5.14B | 4.60B | 4.37B | 5.26B | 4.65B | 4.25B |
| Interest Income | 55.00M | 14.00M | 17.00M | 19.00M | 47.00M | 50.00M | 51.00M | 50.00M | 107.00M | 106.00M | 125.00M | 65.00M | 7.00M | 6.00M | 11.00M | 10.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 287.00M | 167.00M | 192.00M | 183.00M | 192.00M | 193.00M | 153.00M | 149.00M | 133.00M | 130.00M | 116.00M | 80.00M | 59.00M | 59.00M | 77.00M | 105.60M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.02B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 567.00M | 545.00M | 556.00M | 539.00M | 519.00M | 511.00M | 475.00M | 443.00M | 449.00M | 442.00M | 439.00M | 425.00M | 421.00M | 376.00M | 351.00M | 347.60M | 333.90M | 328.70M | 329.30M | 327.80M | 315.50M | 296.50M | 336.20M | 337.80M | 340.20M | 330.30M | 319.90M | 316.30M | 300.30M | 235.10M | 209.60M | 192.50M | 146.20M | 126.20M | 97.00M | 82.00M | 101.30M | 89.30M | 72.20M |
| EBITDA | 4.25B | 4.13B | 4.37B | 4.33B | 4.16B | 4.17B | 4.12B | 4.33B | 3.35B | 4.11B | 4.12B | 4.38B | 4.27B | 3.87B | 3.98B | 3.46B | 3.06B | 2.55B | 2.61B | 2.50B | 2.47B | 2.31B | 2.17B | 2.08B | 1.98B | 1.81B | 1.68B | 1.56B | 1.43B | 1.28B | 1.16B | 991.10M | 427.80M | 680.90M | 532.40M | 445.50M | 485.30M | 421.60M | 349.00M |
| EBITDA Ratio | 21.82% | 27.16% | 28.87% | 26.86% | 25.95% | 27.05% | 26.30% | 28.66% | 33.72% | 23.15% | 22.93% | 25.25% | 25.47% | 26.77% | 25.88% | 21.97% | 22.35% | 22.54% | 22.93% | 24.14% | 24.93% | 24.52% | 23.17% | 21.46% | 22.52% | 20.24% | 18.80% | 18.93% | 23.35% | 18.02% | 17.30% | 14.44% | 6.49% | 11.92% | 8.62% | 9.55% | 11.64% | 7.64% | 6.55% |
| Operating Income | 3.98B | 4.34B | 4.47B | 3.89B | 3.55B | 3.69B | 3.59B | 3.84B | 2.79B | 3.56B | 3.56B | 3.89B | 3.84B | 3.79B | 3.62B | 3.02B | 2.65B | 2.16B | 2.22B | 2.12B | 2.17B | 2.01B | 1.86B | 1.72B | 1.64B | 1.48B | 1.36B | 1.25B | 1.13B | 1.05B | 954.30M | 798.60M | 281.60M | 554.70M | 435.40M | 363.50M | 384.00M | 332.30M | 276.80M |
| Operating Income Ratio | 20.48% | 24.13% | 25.68% | 23.59% | 22.65% | 23.76% | 23.22% | 25.25% | 17.39% | 20.59% | 20.41% | 22.76% | 22.95% | 24.35% | 23.59% | 19.70% | 19.24% | 17.65% | 19.44% | 20.05% | 21.87% | 21.66% | 19.74% | 18.39% | 17.98% | 16.54% | 15.00% | 14.24% | 13.47% | 13.83% | 13.36% | 11.40% | 4.65% | 9.75% | 8.64% | 7.68% | 6.80% | 6.67% | 6.12% |
| Total Other Income/Expenses | -592.00M | -233.00M | -245.00M | -238.00M | -253.00M | -230.00M | -220.00M | -99.00M | -26.00M | -24.00M | 9.00M | -118.00M | -52.00M | -59.00M | -77.00M | -15.70M | -89.50M | -158.70M | -80.70M | -151.20M | -124.10M | -142.80M | -166.10M | -173.30M | -245.20M | -234.10M | -255.90M | -291.20M | -762.00M | -169.50M | -118.10M | -70.70M | -63.70M | -43.30M | 11.50M | -113.20M | -261.20M | -35.30M | -1.30M |
| Income Before Tax | 3.39B | 2.66B | 3.09B | 3.65B | 3.30B | 3.46B | 3.49B | 3.74B | 2.76B | 3.53B | 3.57B | 3.87B | 3.79B | 3.43B | 3.54B | 2.93B | 2.50B | 2.00B | 2.08B | 2.00B | 2.04B | 1.87B | 1.67B | 1.57B | 1.39B | 1.25B | 1.10B | 954.60M | 363.50M | 879.90M | 836.20M | 727.90M | 217.90M | 511.40M | 446.90M | 250.30M | 122.80M | 297.00M | 275.50M |
| Income Before Tax Ratio | 17.43% | 14.80% | 17.72% | 22.14% | 21.03% | 22.29% | 22.56% | 24.60% | 17.23% | 20.45% | 20.46% | 22.67% | 22.64% | 22.04% | 23.08% | 19.08% | 18.10% | 16.36% | 18.24% | 18.92% | 20.62% | 20.12% | 17.70% | 16.75% | 15.29% | 13.93% | 12.17% | 10.91% | 4.35% | 11.60% | 11.71% | 10.39% | 3.60% | 8.99% | 8.87% | 5.29% | 2.17% | 5.96% | 6.09% |
| Income Tax Expense | 937.00M | 693.00M | 749.00M | 787.00M | 774.00M | 906.00M | 1.31B | 1.15B | 1.22B | 1.19B | 1.16B | 1.24B | 1.24B | 1.12B | 1.14B | 967.90M | 759.10M | 648.40M | 727.60M | 675.30M | 620.60M | 582.00M | 522.10M | 503.40M | 457.30M | 401.50M | 361.90M | 319.60M | 191.50M | 299.70M | 288.10M | 250.90M | 93.00M | 190.40M | 166.90M | 97.60M | 68.80M | 119.50M | 107.70M |
| Net Income | 2.30B | 1.79B | 2.17B | 2.70B | 2.37B | 2.40B | 2.02B | 2.44B | 1.38B | 2.18B | 2.24B | 2.47B | 2.43B | 2.20B | 2.29B | 1.96B | 1.74B | 1.35B | 1.35B | 1.33B | 1.42B | 1.29B | 1.15B | 1.06B | 937.30M | 848.60M | 740.40M | 635.00M | 172.00M | 580.20M | 189.90M | 477.00M | 124.90M | 321.00M | 280.00M | 192.80M | 54.00M | 177.50M | 171.90M |
| Net Income Ratio | 11.82% | 9.93% | 12.43% | 16.36% | 15.08% | 15.44% | 13.10% | 16.06% | 8.63% | 12.62% | 12.86% | 14.47% | 14.53% | 14.15% | 14.95% | 12.77% | 12.60% | 11.06% | 11.86% | 12.54% | 14.35% | 13.86% | 12.16% | 11.37% | 10.28% | 9.46% | 8.18% | 7.26% | 2.06% | 7.65% | 2.66% | 6.81% | 2.06% | 5.64% | 5.56% | 4.07% | 0.96% | 3.56% | 3.80% |
| EPS | 2.78 | 2.13 | 2.56 | 3.15 | 2.76 | 2.76 | 2.30 | 2.74 | 1.53 | 2.38 | 2.41 | 2.60 | 2.49 | 2.23 | 2.27 | 1.91 | 1.68 | 1.29 | 1.27 | 1.23 | 1.30 | 1.17 | 1.01 | 0.91 | 0.79 | 0.70 | 0.61 | 0.53 | 0.13 | 0.48 | 0.14 | 0.37 | 0.10 | 0.28 | 0.25 | 0.18 | 0.05 | 0.16 | 0.14 |
| EPS Diluted | 2.77 | 2.13 | 2.55 | 3.14 | 2.75 | 2.75 | 2.28 | 2.72 | 1.52 | 2.36 | 2.38 | 2.58 | 2.47 | 2.15 | 2.19 | 1.83 | 1.60 | 1.23 | 1.22 | 1.17 | 1.23 | 1.10 | 0.95 | 0.85 | 0.74 | 0.65 | 0.56 | 0.49 | 0.13 | 0.45 | 0.13 | 0.35 | 0.10 | 0.27 | 0.24 | 0.18 | 0.05 | 0.16 | 0.14 |
| Weighted Avg Shares Out | 827.40M | 836.40M | 845.00M | 856.80M | 859.10M | 870.60M | 881.80M | 891.80M | 902.20M | 915.10M | 930.80M | 952.20M | 976.60M | 975.60M | 999.00M | 1.01B | 1.02B | 1.03B | 1.04B | 1.06B | 1.07B | 1.09B | 1.11B | 1.15B | 1.17B | 1.18B | 1.18B | 1.17B | 1.16B | 1.17B | 1.25B | 1.25B | 1.10B | 1.06B | 1.08B | 1.07B | 1.07B | 1.11B | 929.71M |
| Weighted Avg Shares Out (Dil) | 829.20M | 838.80M | 848.30M | 859.30M | 861.10M | 873.00M | 887.80M | 898.40M | 909.70M | 924.30M | 939.90M | 960.20M | 984.00M | 1.02B | 1.05B | 1.07B | 1.07B | 1.08B | 1.09B | 1.12B | 1.13B | 1.16B | 1.19B | 1.23B | 1.25B | 1.27B | 1.27B | 1.25B | 1.16B | 1.26B | 1.29B | 1.32B | 1.10B | 1.14B | 1.12B | 1.07B | 1.07B | 1.11B | 929.71M |
Sell Alert: 3 Dividend Aristocrats That May Kill Your Passive Income Snowball
Dividend stocks are my favored way for generating passive income for retirement. Passive income is generated with minimal effort once set up, and can snowball beautifully as dividends are reinvested. Not all Dividend Aristocrats are good for a massive dividend...
Colgate's (CL) Strategic Efforts Seem Prudent: Apt to Hold?
Colgate (CL) benefits from robust pricing and productivity initiatives. The company's innovation strategy also bodes well.
Colgate-Palmolive (CL) Could Be a Great Choice
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Colgate-Palmolive (CL) have what it takes?
My Dividend Stock Portfolio: New May Dividend Record - 101 Holdings With 22 Buys
Investment activity remained high in April, focusing on BDCs aiming to increase dividend income by at least $100 each month. Main portfolio picks included Ares Capital, Hercules Capital, Goldman Sachs BDC, and MidCap Financial Investment Corporation. Adjusted dividend income hit...
Colgate Declares Regular Quarterly Dividend
NEW YORK--(BUSINESS WIRE)--The Board of Directors of Colgate-Palmolive Company (NYSE:CL) today declared a quarterly cash dividend of $0.50 per common share, payable on August 15, 2024, to shareholders of record on July 19, 2024. The Company has paid uninterrupted dividends...
3 Dividend Stocks That Have Been Keeping Shareholders Happy for 50 Years
If dividend income is what you are looking for, several dependable dividend stocks can help generate passive income. But, in times of market uncertainty and inflationary periods, these companies may pause the dividends.
Colgate-Palmolive Company (CL) Annual Evercore ISI Consumer and Retail Conference (Transcript)
Colgate-Palmolive Company (NYSE:CL ) Annual Evercore ISI Consumer and Retail Conference June 11, 2024 12:30 PM ET Company Participants John Faucher - Chief Investor Relations Officer & M&A Conference Call Participants Robert Ottenstein - Evercore ISI Robert Ottenstein Good afternoon,...
The 7 Best Stocks to Buy to Avoid June Gloom
While it's just an aphorism, the adage sell in May and go away generally rings true. Seasonality makes certain months not pleasant for the equities sector, though there are best stocks to avoid June gloom.
Dividend Delicacies: 3 Stocks That Will Whet Your Appetite for Consistent Payouts
The stock market is not known for consistency. Look at things like hypergrowth technology companies or meme stocks: These sorts of assets tend to require active monitoring and trading to achieve best results.
7 Reliable Stocks That Deliver Come Rain or Shine
The stock market is unpredictable, and it is impossible to time it. Inflation, recession, low consumer spending and geopolitical issues can impact your investment portfolio.
Source: https://incomestatements.info
Category: Stock Reports